HSA — authorised 30 September 2013
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: likely_approved
HSA authorised Trintellix on 30 September 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 30 September 2013.
TAKEDA PHARMS USA holds the Singaporean marketing authorisation.